Transfusion and Apheresis Science

Papers
(The TQCC of Transfusion and Apheresis Science is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study140
Treatment for emerging viruses: Convalescent plasma and COVID-19110
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection64
Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia62
Inventory management in blood supply chain considering fuzzy supply/demand uncertainties and lateral transshipment52
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma48
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia38
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia35
COVID-19 and the ABO blood group connection34
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine34
Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario34
CRISPR/Cas9 gene editing for curing sickle cell disease33
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis33
Patient blood management: The best approach to transfusion medicine risk management33
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy31
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma30
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike30
Convalescent plasma therapy in patients with COVID-1930
Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection28
Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?27
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma25
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation24
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries24
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan22
The true historical origin of convalescent plasma therapy22
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies21
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma18
No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-1917
Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients17
Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic17
Umbilical cord blood: Current uses for transfusion and regenerative medicine16
Symmetrical peripheral gangrene in critical illness16
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome16
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review16
Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia15
Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies14
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-1914
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunogl13
Therapeutic plasma exchange in the pediatric intensive care unit: A single-center 5-Year experience13
Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases13
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia13
RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates13
Convalescent plasma therapy in patients with COVID-1913
Dwindling blood reserves: An ominous downside of COVID-19 pandemic13
Unit-to-unit variability in the deformability of red blood cells12
Therapeutic plasma exchange: A potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit12
Patient blood management implementation in light of new Italian laws on patient's safety12
Wound healing effect of autologous fibrin glue and polyglycolic acid sheets in a rat back skin defect model12
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review12
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management12
Reduced deformability of stored red blood cells is associated with generation of extracellular vesicles12
Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption12
Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran11
Role of the AB0 blood group in COVID-19 infection and complications: A population-based study11
The frequent and the unusual red cell phenotypes in Indian blood donors: A quest for rare donors11
Comparison of allogenic stem cell transplantations performed with frozen or fresh stem cell products with regard to GVHD and mortality11
Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report11
COVID-19: Further evidence of no transfusion transmission11
The role of therapeutic plasmapheresis in patients with hyperthyroidism11
Is the Italian consent to transfusion really informed? A medico-legal analysis between old ghosts and new evidence11
Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation10
NEW HORIZONS ON STEM CELL CRYOPRESERVATION THROUGH THE ARTIFICIAL EYES OF CD 34+, USING MODERN FLOW CYTOMETRY TOOLS10
Cellular therapy for the treatment of solid tumors10
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-1910
Leukoreduction makes a difference: A pair proteomics study of extracellular vesicles in red blood cell units10
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors10
Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn10
Understanding the demand for phenotyped red blood cell units and requests to perform molecular red blood cell typing for Australian patients9
Peripheral Blood Stem Cell Mobilization and Collection in Pediatric Healthy Sibling Donors Weighing 20 Kilograms or Less; Algerian Experience9
People with blood disorders can be more vulnerable during COVID-19 pandemic: A hypothesis paper9
Artificial intelligence meets hematology9
Emergency Supply Policy of Cryopreserved RBC and PLT: The Czech Republic Concept9
Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India9
A look-back at convalescent plasma to treat COVID-199
Effects of cell concentration, time of fresh storage, and cryopreservation on peripheral blood stem cells9
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes9
The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients9
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients9
Knowledge, attitude and practice of blood donation and the role of religious beliefs among health sciences undergraduate students9
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?9
Non-fungible tokens: Stem cell transplantation in the blockchain8
In vitro platelet production for transfusion purposes: Where are we now?8
Assessment of serum iron stores in regular plateletpheresis donors8
Preparation of packed red blood cell units in the blood bank: Alteration in red blood cell deformability8
Anti-SARS-CoV-2 hyperimmune plasma workflow8
Optimizing pediatric peripheral blood stem cell collection8
Mesenchymal stromal cells: Getting ready for clinical primetime8
Optimal timing of apheresis for the efficient mobilization of peripheral blood progenitor cells recruited by high-dose granulocyte colony-stimulating factor in healthy donors8
Baseline haemoglobin and thromboelastometry are predictive of red blood cell requirements and one-year mortality in liver transplantation8
Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH)8
Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and ed8
Inherited coagulation disorders in Turkish children: A retrospective, single-center cohort study8
Effect of Cord Blood Platelet Gel on wound healing capacity of human Mesenchymal Stromal Cells8
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?8
Motivators, barriers and communication channels for blood donation in relation to students at a university in Spain8
Characteristics and causes of pre-donation deferrals at a Chinese blood center7
Therapeutic plasma exchange in critically ill children: experience of the pediatric intensive care unit of two centers in Chile7
A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Itali7
Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions7
Preoperative plasmapheresis experience in Graves’ disease patients with anti-thyroid drug-induced hepatotoxicity7
Apoptosis as an underlying mechanism in lymphocytes induced by riboflavin and ultraviolet light7
N-acetylcysteine reduce the stress induced by cold storage of platelets: A potential way to extend shelf life of platelets7
A serological investigation and genotyping of Toxoplasma gondii among Iranian blood donors indicates threat to health of blood recipients7
Cargo-laden erythrocyte ghosts target liver mediated by macrophages7
Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M1017
Sickle cell disease in the new era: advances in drug treatment7
Spotlight on animal models of acute traumatic coagulopathy: an update7
Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during bloo7
The successful management of an elderly Covid-19 infected patient by plasmapheresis7
Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors7
Platelet and extracellular vesicles in COVID-19 infection and its vaccines7
Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients7
Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-196
Complete neurological recovery from fat embolism syndrome in sickle cell disease after sequential red cell exchange transfusion and therapeutic plasma exchange6
Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders6
Renal function and the oxidative status among children with thalassemia major and healthy controls: A cross-sectional study6
An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research6
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia6
Emerging use of machine learning and advanced technologies to assess red cell quality6
Blood donor deferral periods after COVID-19 vaccination6
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection6
Therapeutic plasma exchange and continuous renal replacement therapy in pediatric dengue-associated acute liver failure: A case series from Vietnam6
The association of ABO blood group with the asymptomatic COVID-19 cases in India6
An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine6
Blood donation and heavy metal poisoning in developing nations: Any link?6
The HLA-DRB1*11 group-specific allele is a predictor for alloantibody production in the transfusion-dependent thalassemia patients6
Attenuation of age-elevated blood factors by repositioning plasmapheresis: A novel perspective and approach6
ROTEM in the setting of liver transplant surgery reduces frozen plasma transfusion6
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission6
Midline catheter as effective device in healthy allogeneic donors and patients without an adequate peripheral venous access for HPC collection by apheresis: Preliminary experience at IEO6
Fetal and neonatal allo-immune response6
Patient blood management and blood conservation – Complimentary concepts and solutions for blood establishments and clinical services in South Africa and beyond6
Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 20216
Role of therapeutic plasma exchanges in systemic vasculitis6
Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India6
Analysis of ABO grouping discrepancies among patients from a tertiary hospital in Korea6
Gene therapy for hemoglobinopathies6
The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic6
Acquired hemophilia A following COVID-19 vaccination – The importance of prompt diagnosis: A case report6
Double filtration plasmapheresis – 10-year pediatric experience as an alternative to plasma exchange5
Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India5
Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study5
Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross5
The importance of microbiota in hematology5
Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice5
SARS-CoV-2 and cancer: the intriguing and informative cross-talk5
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan5
Analysis of extracorporeal photopheresis within the frame of the WAA register5
Transfusion outcome for volume- and plasma-reduced platelet concentrates for pediatric patients5
Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013–20205
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series5
Transient elastography of liver: Could it be a guide for diagnosis and management strategy in hepatic veno-occlusive disease (sinusoidal obstruction syndrome)?5
Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease5
Classification of major and minor blood group antigens in the Kuwaiti Arab population5
How do I see the production of engineered blood cells available for transfusion?5
“Dual-gene” malaria-resistance: Therapeutically-rational exchange (T-REX) of group-O sickle trait and group-O C-traittrait red blood cells can be evaluated in Benin and Nigeria5
Iatrogenic anaemia and transfusion thresholds in ICU patients with COVID-19 disease at a tertiary care hospital5
Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis5
Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status5
Platelet-rich plasma for the treatment of burn wounds: A meta-analysis of randomized controlled trials5
Platelet supernatant with longer storage inhibits tumor cell growth5
Hepatitis-associated aplastic anemia in pediatric patients: single center experience5
RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations – Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-5
Q fever as a rare cause of hemophagocytic lymphohistiocytosis: Case report5
Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies5
Erythrocyte Alloimmunity and Genetic Variance: Results from the Collaborative Study of Alloimmunity to Antigen Diversity in Asian Populations (All ADP)5
Comparative evaluation of ADVIA Centaur® XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors5
Novel autologous, high concentrated fibrin as advanced hemostatic agent for coronary surgery5
Transfusion reactions: A retrospective analysis of the Iranian national haemovigilance system (INHS) data5
An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy4
Plasma supply in the United States4
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program4
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment4
Hemolytic anemia and plasma exchange4
Labile iron, ROS, and cell death are prominently induced by haemin, but not by non-transferrin-bound iron4
Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: implications in the pathophysiology and treatment of inflammation4
Acquired methemoglobinemia: A systematic review of reported cases4
Effects of ultrasound guided leukocyte-rich platelet-rich plasma (LR-PRP) injection in patients with pes anserinus tendinobursitis4
Secondary alloanti-D immunization post transfusion of “Asia type” DEL red blood cells4
Can plasma exchange therapy be an option for the treatment of SARS-CoV-2 Related Splenial Lesion Syndrome: Two cases from the pediatric intensive care unit4
Transfusion transmitted babesiosis: A systematic review of reported cases4
Donor safety in an individualized plasmapheresis program – Results of an interim analysis4
Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximab4
Successful autologous peripheral blood stem cell collection using large volume leukapheresis in patients with very low or undetectable peripheral blood CD34+ progenitor cells4
Neonatal exchange transfusion: Experience in Korea4
Is it necessary to add the eluate testing to the direct antiglobulin test to improve the detection of maternal erythrocyte alloantibodies?4
COVID-19 antibody donation using immunoadsorption: Report of two cases4
Thrombin Generation in a patient with Triple Positive Antiphospholipid Syndrome Treated with Three Different Anticoagulants4
Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis4
Bone marrow CD34 positive cells may be suitable for collection after death4
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation4
Blood supply management during the Covid-19 pandemic: Experience in a tertiary referral hospital in Malaysia4
Engraftment after autologous hematopoietic stem cell transplantation in patients mobilized with Plerixafor: A retrospective, multicenter study of a large series of patients4
Genotyping of blood groups in alloimmunized patients with β-thalassemia major by T-ARMS-PCR and multiplex-aso-pcr4
Documentation errors in transfusion chain: Challenges and interventions4
Thrombocytopenia due to rivaroxaban: A rare adverse effect4
Molecular identification of the emerging Human Gemykibivirus-2 (HuGkV-2) among Brazilian blood donors4
Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials4
Inferior prognosis in poor mobilizing myeloma patients4
Investigating the production of platelet lysate obtained from low volume Cord Blood Units: Focus on growth factor content and regenerative potential4
Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study4
Whole blood derived covid convalescent plasma: A practical experience from India4
Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy4
Use of granulocyte transfusion in early period in life-threatening infections of pediatric hematology and oncology patients: A single-center experience4
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection4
Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and cost4
Changes in blood donation and utilization secondary to Covid-19 outbreak4
The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates4
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico4
COVID-19-associated Evans syndrome: A case report and review of the literature4
Blood transfusion trends by disease category in the United States, 2000 to 20144
Idiopathic TTP in the Middle East: Epidemiology and clinical outcomes in infection associated episodes3
DMSO (Me2SO) concentrations of 1-2% in combination with pentaisomaltose are effective for cryopreservation of T cells3
−80 °C deep frozen erythrocytes during military operations. The Dutch frozen concept3
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series3
PD-1 blockader-associated atypical hemophagocytic lymphohistiocytosis: A cautionary case report3
Identifying the possible causes of recurrent leukodepletion filter blockage in whole blood donations3
Plasmapheresis in ABO incompatible kidney transplant3
Hepcidin as a diagnostic marker of iron deficiency in blood donors3
Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience3
The effect of a viscoelastic-guided bleeding algorithm implementation on blood products use in adult liver transplant patients. A propensity score-matched before-after study3
Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma3
A survey of blood transfusion errors in Aichi Prefecture in Japan: Identifying major lapses threatening the safety of transfusion recipients3
Reduced volume of red blood cell priming is safe for pediatric patients undergoing therapeutic plasma exchange3
Transfusion-associated babesiosis in China: A case report3
Survey based cross-sectional study to analyse the variation of practices at blood centres during COVID-19 pandemic in India3
Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)3
Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn3
Perceptions and practices of the Brazilian LGBT+ population toward blood donation3
Seroepidemiology of Toxoplasma gondii in blood donors in Portugal3
Pancytopenia in a newborn due to maternal piperacillin and human leukocyte antigen antibodies3
The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned3
Basic principles of therapeutic plasma exchange3
How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?3
Comparison of efficacy of packed red blood cell transfusion based on its hemoglobin content versus the standard transfusion practice in thalassemia major patients (HEMOCON study)3
Benford’s law and metabolomics: A tale of numbers and blood3
Anti-A and anti-A,B monoclonal antisera with high titers favor the detection of A weak phenotypes3
Comparison between intraoperative bleeding score and ROTEM® measurements to assess coagulopathy during major pediatric surgery3
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease3
Urgent therapeutic plasma exchange3
Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience3
Therapeutic plasma exchange for envenomation: Is it reasonable?3
COVID 19 convalescent plasma: Is there still a place for CCP?3
Factors influencing voluntary blood donation practice among university students of Bangladesh3
Blood donors, iron deficiency and supplementation options – Will clinical trials help moving forward?3
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma3
Leukapheresis for CAR-T cell production and therapy3
Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma3
Identifying correlations between donor demographics and isohemagglutinin titers as a potential method to screen for low-titer group O whole blood3
Human placenta-derived mesenchymal stromal cells transfusion in a critically Ill infant diagnosed with Coronavirus Disease 2019 (COVID-19): A case report3
0.037598133087158